Related Experiment Videos
Prostate disease in older men: 1. Benign hyperplasia
1Division of Urology, University of Connecticut Health Center, Farmington, USA.
Hospital Practice (1995)
|May 15, 1997
Summary
Alpha 1-adrenergic blockers and 5 alpha-reductase inhibitors provide medical alternatives for prostate conditions. Blockers suit smaller glands with obstructive symptoms, while inhibitors are better for larger glands.
Area of Science:
- Urology
- Pharmacology
Background:
- Benign prostatic hyperplasia (BPH) management traditionally involves watchful waiting or surgery.
- Medical therapies offer alternatives to invasive procedures.
Observation:
- Obstructive symptoms are common in patients with BPH.
- Prostate size varies among patients presenting with symptoms.
Findings:
- Alpha 1-adrenergic blockers are effective for patients with obstructive symptoms and smaller prostates.
- 5 alpha-reductase inhibitors are preferred for patients with larger prostate glands.
Implications:
- Tailoring medical therapy based on prostate size can optimize treatment outcomes.
- Pharmacological interventions provide viable, less invasive options for BPH management.